Log In
Print this Print this

Tefina (formerly TBS-2)

  Manage Alerts
Collapse Summary General Information
Company Acerus Pharmaceuticals Corp.
DescriptionBioadhesive intranasal low-dose gel formulation of testosterone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationSexual dysfunction
Indication DetailsTreat anorgasmia in women
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today